Local Opinion: FTC is right to investigate pharmacy benefit managers
Sharon Joseph Special to the Arizona Daily Star As someone who works closely with the patient community, I feel it is my responsibility...
Local Opinion: FTC is right to investigate pharmacy benefit managers
These 'Rebates' Don't Result in Savings
Hospitals and for-profit PBMs are diverting billions in 340B savings from patients in need
Consumer Alert: Paying too much for prescription drugs? A middleman may be to blame
Pharmacy Benefit Mafia: The Secret Health Care Monopolies Jacking Up Drug Prices Abusing Patients
Guest Column: PBMs are hurting Texans with disabilities
AG Balderas Announces $13.7 Million Settlement With Centene Corporation Over PBM Investigation
Congress should shield patients from deceptive policies that increase their medication costs
Prior Authorization Continues to Burden Physicians, Adversely Impact Treatment, Survey Finds
Medical Middlemen: Broken system making it harder for hospitals & patients to get life-saving drugs
Rein in profiteering by drug-industry middlemen
Senators decry lack of 'sunlight' on PBM processes, push for reforms in transparency
Asking the Wrong Questions
Good, go after rising drug prices. But first target the real problem
Rein In Profiteering by Drug-Industry Middlemen
NCCN Panel: How White Bagging Is Tied to High Drug Costs
Angela Storseth-Cooper Describes PBM Influence in Community Oncology, State-Level Interventions
Why the FTC should reconsider its vote on probing pharmacy benefit managers
PHARMACY ALERT: PBMs Steer Patients to PBM-Owned Pharmacies
I’m used to my patients’ prior auth hassles. Then came Mom’s